Prognostic value of LncRNA DLGAP1-AS2 in bladder cancer and its regulatory effect on tumor progression
DLGAP1-AS2 is a potential biomarker for evaluating the severity of BLCA and for predicting clinical prognosis. DLGAP1-AS2 regulates the malignant progression of BLCA via miR-451a.
Authors
- Xiaotong Wu (ORCID: https://orcid.org/0000-0003-2959-5602)
- Huiming Bai
- Yuhui Zhao (ORCID: https://orcid.org/0000-0002-1362-8791)
- Zhigang Zhang (ORCID: https://orcid.org/0000-0001-6237-0902)
- Xiaofeng He (ORCID: https://orcid.org/0000-0001-8255-1874)
- Yi Zheng (ORCID: https://orcid.org/0000-0002-5140-086X)
- Mingzhi Li
- Chao Yu (ORCID: https://orcid.org/0000-0001-8389-1512)
Institutions
- Zhejiang Chinese Medical University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- Zhengzhou City Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1007/s12672-025-03397-z
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00